查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1893535

全球主动植入式医疗设备市场

Active Implantable Medical Devices
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年，全球主动式植入式医疗设备市场规模将达513亿美元。

2024年全球主动植入式医疗设备市场规模估计为328亿美元，预计到2030年将达到513亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为7.7%。本报告分析的细分市场之一－置入式除颤器（ICD）预计将以7.9%的复合年增长率成长，并在分析期结束时达到172亿美元。植入式心臟节律器细分市场预计在分析期间内将以8.6%的复合年增长率成长。

美国市场规模估计为92亿美元，而中国市场预计将以7.3%的复合年增长率成长。

预计2024年，美国主动植入式医疗设备市场规模将达92亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到79亿美元，在2024年至2030年的分析期间内，年复合成长率（CAGR）为7.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期内，这两个市场的年复合成长率将分别达到7.2%和6.2%。在欧洲，德国的年复合成长率预计约为6.3%。

全球主动植入式医疗设备市场－主要市场趋势与驱动因素概述

为什么有源植入式医疗设备正在改变医疗保健产业？

主动植入式医疗设备（AIMD）正在成为医疗产业的变革者，为慢性病管理和改善患者预后提供了前所未有的解决方案。这些器械包括心臟节律器、去心房颤动、神经刺激设备和人工电子耳，旨在植入体内，用于监测、诊断和治疗各种疾病。先进技术与AIMD的融合显着提升了其功能，使其能够持续监测并将即时数据传输给医疗服务提供者。这种能力不仅能够实现及时的医疗干预，还有助于降低医院再入院率和医疗成本。 AIMD的演进代表着个人化医疗的重大飞跃，它能够提供针对每位患者特定需求的客製化治疗方案。

技术进步将如何提高AIMD的有效性？

技术创新在人工智慧辅助医疗器材（AIMD）的研发和疗效提升中发挥了关键作用。微电子、无线通讯和节能电源的应用，使这些设备体积更小、可靠性更高、使用寿命更长。生物相容性材料的创新提高了植入的安全性和耐用性，并降低了不良反应和设备故障的风险。此外，人工智慧和机器学习演算法的集成，使AIMD能够适应患者不断变化的生理状况，并优化治疗效果。这些技术进步不仅提升了AIMD的性能，也拓展了其应用范围，使其能够治疗更多种类的疾病。因此，患者能够受益于更有效、创伤更小的治疗方案，从而提高生活质量，延长生存期。

影响AIMD的趋势和市场动态有哪些？

人工智慧辅助医疗器材（AIMD）市场受到多种新兴趋势和市场动态的影响。全球人口老化是推动AIMD需求成长的关键因素，因为心血管疾病、神经系统疾病和听力障碍等慢性疾病的盛行率会随着老龄化的增长而增加。此外，糖尿病和肥胖等文明病的增加进一步提高了对先进医疗干预的需求。法律规范和核准流程日趋严格，以确保AIMD的安全性和有效性，进而提高病患的信任度和接受度。此外，远端医疗和远距监测技术的进步增强了AIMD的功能，实现了患者与医疗服务提供者之间的无缝连接。这些趋势凸显了AIMD在应对现代世界复杂医疗挑战方面日益增长的重要性。

什么因素推动了主动植入式医疗设备市场的成长要素？

有源植入式医疗设备市场的成长受多种因素驱动。其中一个关键驱动因素是持续的技术创新，这些创新不断提升了此类器材的功能和可靠性。慢性病盛行率的上升和人口老化也带来了对主动植入式医疗器材的巨大需求。此外，医疗基础设施的扩张，尤其是在新兴市场，为有源植入式医疗器材製造商提供了巨大的成长机会。成功的临床结果和医疗设备製造商的大力市场推广也提高了病患对这些器材的认知度和接受度。监管支持和优惠的报销政策进一步加速了市场普及。此外，微创手术的趋势以及主动植入式医疗器材与数位健康平台在远端监测和管理方面的整合也推动了市场发展。这些因素共同促成了主动植入式医疗设备市场的强劲成长和动态发展，使其成为现代医疗保健服务的重要组成部分。

部分：

依产品类型（置入式除颤器、植入式心臟节律器、植入式心电图监视器/植入式循环记录器、心室辅助装置、神经神经刺激设备、植入式助听器）

分析的公司范例

  • Abbott Laboratories
  • Biotronik SE &Co. KG
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • MED-EL Elektromedizinische Gerate Gesellschaft mbH
  • Medtronic PLC
  • Nurotron Biotechnology Co., Ltd.
  • Sonova AG
  • William Demant Holding A/S

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，革新市场和竞争情报分析。

Market Glass, Inc. 并没有采用查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括影片文字稿、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对各区域市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口情况（成品和OEM产品）预测各公司的竞争地位变化。这种复杂多变的市场现实将对竞争对手产生多方面的影响，包括销货成本增加、盈利下降以及供应链重组。

目录

第一章 分析方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP10058

Global Active Implantable Medical Devices Market to Reach US$51.3 Billion by 2030

The global market for Active Implantable Medical Devices estimated at US$32.8 Billion in the year 2024, is expected to reach US$51.3 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$17.2 Billion by the end of the analysis period. Growth in the Implantable Cardiac Pacemakers segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.2 Billion While China is Forecast to Grow at 7.3% CAGR

The Active Implantable Medical Devices market in the U.S. is estimated at US$9.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.9 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Global Active Implantable Medical Devices Market - Key Trends and Drivers Summarized

Why Are Active Implantable Medical Devices Revolutionizing Healthcare?

Active implantable medical devices (AIMDs) have emerged as a game-changer in the healthcare industry, offering unprecedented solutions for managing chronic diseases and improving patient outcomes. These devices, which include pacemakers, defibrillators, neurostimulators, and cochlear implants, are designed to be implanted into the body to monitor, diagnose, and treat various medical conditions. The integration of advanced technologies in AIMDs has significantly enhanced their functionality, enabling continuous monitoring and real-time data transmission to healthcare providers. This capability not only allows for timely medical interventions but also reduces hospital readmissions and healthcare costs. The evolution of AIMDs represents a significant leap forward in personalized medicine, providing tailored treatments that cater to the specific needs of individual patients.

How Do Technological Advancements Boost AIMDs' Effectiveness?

Technological advancements have played a pivotal role in the development and effectiveness of AIMDs. The incorporation of microelectronics, wireless communication, and energy-efficient power sources has made these devices smaller, more reliable, and longer-lasting. Innovations in biocompatible materials have improved the safety and durability of implants, reducing the risk of adverse reactions and device failure. Moreover, the integration of artificial intelligence and machine learning algorithms enables AIMDs to adapt to the changing physiological conditions of patients, optimizing therapeutic outcomes. These technological strides not only enhance the performance of AIMDs but also expand their applications, making them suitable for a wider range of medical conditions. As a result, patients benefit from more effective and less invasive treatment options, leading to better quality of life and prolonged survival rates.

What Trends and Market Dynamics Are Influencing AIMDs?

The AIMD market is influenced by several emerging trends and market dynamics. The aging global population is a significant factor driving the demand for AIMDs, as the prevalence of chronic diseases such as cardiovascular disorders, neurological conditions, and hearing impairments increases with age. Additionally, the rise in lifestyle-related diseases, such as diabetes and obesity, has further escalated the need for advanced medical interventions. Regulatory frameworks and approval processes are becoming more stringent, ensuring the safety and efficacy of AIMDs, which in turn boosts patient confidence and adoption rates. Furthermore, advancements in telemedicine and remote monitoring technologies are complementing the functionality of AIMDs, enabling seamless connectivity between patients and healthcare providers. These trends underscore the growing importance of AIMDs in addressing the complex healthcare challenges of the modern world.

What Drives the Growth in the Active Implantable Medical Devices Market?

The growth in the active implantable medical devices market is driven by several factors. One of the primary drivers is the continuous technological innovation that enhances the capabilities and reliability of these devices. The increasing prevalence of chronic diseases and the growing aging population create a substantial demand for AIMDs. Moreover, the expanding healthcare infrastructure, particularly in emerging markets, provides significant growth opportunities for AIMD manufacturers. Patient awareness and acceptance of these devices are also on the rise, driven by successful clinical outcomes and extensive marketing efforts by medical device companies. Regulatory support and favorable reimbursement policies further accelerate market adoption. Additionally, the trend towards minimally invasive surgical procedures and the integration of AIMDs with digital health platforms for remote monitoring and management propel the market forward. These factors collectively contribute to the robust growth and dynamic evolution of the active implantable medical devices market, making it a critical component of modern healthcare delivery.

SCOPE OF STUDY:

The report analyzes the Active Implantable Medical Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators, Implantable Hearing Devices)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • MED-EL Elektromedizinische Gerate Gesellschaft m.b.H.
  • Medtronic PLC
  • Nurotron Biotechnology Co., Ltd.
  • Sonova AG
  • William Demant Holding A/S

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Active Implantable Medical Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Spurs Demand for AIMDs
    • Aging Population Expands Addressable Market Opportunity for AIMDs
    • Technological Innovations Propel Growth in Active Implantable Medical Devices
    • Advances in Microelectronics Strengthen Business Case for AIMDs
    • Integration of AI and Machine Learning Accelerates Demand for Intelligent Implants
    • Enhanced Biocompatible Materials Drive Adoption of Safer AIMDs
    • Telemedicine and Remote Monitoring Technologies Propel Market Growth
    • Minimally Invasive Procedures Sustain Growth in AIMD Adoption
    • Expanding Healthcare Infrastructure in Emerging Markets Expands Market Opportunities
    • Innovations in Power Sources and Energy Efficiency Propel AIMD Advancements
    • Digital Health Integration Drives Demand for Connected AIMDs
    • Data Security and Privacy Concerns Create Challenges and Opportunities for AIMDs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Active Implantable Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Active Implantable Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Implantable Cardioverter Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Implantable Cardioverter Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Implantable Cardioverter Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Implantable Cardiac Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Implantable Cardiac Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Implantable Cardiac Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Ventricular Assist Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Ventricular Assist Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Ventricular Assist Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Implantable Hearing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Implantable Hearing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Implantable Hearing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Active Implantable Medical Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Implantable Heart Monitors / Insertable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Neurostimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Neurostimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Neurostimulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030
  • JAPAN
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030
  • CHINA
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: China 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030
  • EUROPE
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Active Implantable Medical Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Active Implantable Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Europe 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030
  • FRANCE
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 41: France Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: France Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: France 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030
  • GERMANY
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Germany 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 47: Italy Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Italy Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Italy 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: UK Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: UK 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of Europe 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Active Implantable Medical Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 59: Rest of World Recent Past, Current & Future Analysis for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Rest of World Historic Review for Active Implantable Medical Devices by Product - Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Rest of World 15-Year Perspective for Active Implantable Medical Devices by Product - Percentage Breakdown of Value Sales for Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Implantable Heart Monitors / Insertable Loop Recorders, Ventricular Assist Device, Neurostimulators and Implantable Hearing Devices for the Years 2015, 2025 & 2030

IV. COMPETITION